[Federal Register Volume 85, Number 138 (Friday, July 17, 2020)]
[Notices]
[Pages 43576-43577]
[FR Doc No: 2020-15484]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. CD20-7-000]

Los Angeles County Public Works; Notice of Preliminary
Determination of a Qualifying Conduit Hydropower Facility and
Soliciting Comments and Motions To Intervene

    On July 8, 2020, as supplemented on July 9, 2020, Los Angeles
County Public Works filed a notice of intent to construct a qualifying
conduit hydropower facility, pursuant to section 30 of the Federal
Power Act (FPA). The proposed M5E Pressure Reducing Station
Hydroelectric Project would have an installed capacity of 430 kilowatts
(kW), and would be located along an existing municipal water pipeline
belonging to the applicant near Palmdale, Los Angeles County,
California.
    Applicant Contact: Eric Melander, 5500 Blue Heron Lane, Deming,
Washington 98244, Phone No.<PHONE_NUMBER>, Email:
<EMAIL_ADDRESS>    FERC Contact: Christopher Chaney, Phone No.<PHONE_NUMBER>, Email:
<EMAIL_ADDRESS>    Qualifying Conduit Hydropower Facility Description: The proposed
project would consist of: (1) Two 215-kW turbine-generators within an
existing an approximately 51-foot by 38-foot building at the M5E
Pressure Reducing Station; and (2) appurtenant facilities. The proposed
project would have an estimated annual generation of approximately
1,236 megawatt-hours.
    A qualifying conduit hydropower facility is one that is determined
or deemed to meet all the criteria shown in the table below.

      Table 1--Criteria for Qualifying Conduit Hydropower Facility
------------------------------------------------------------------------
                                                               Satisfies
       Statutory provision                Description            (Y/N)
------------------------------------------------------------------------
FPA 30(a)(3)(A)..................  The conduit the facility           Y
                                    uses is a tunnel, canal,
                                    pipeline, aqueduct,
                                    flume, ditch, or similar
                                    manmade water conveyance
                                    that is operated for the
                                    distribution of water
                                    for agricultural,
                                    municipal, or industrial
                                    consumption and not
                                    primarily for the
                                    generation of
                                    electricity.
FPA 30(a)(3)(C)(i)...............  The facility is                    Y
                                    constructed, operated,
                                    or maintained for the
                                    generation of electric
                                    power and uses for such
                                    generation only the
                                    hydroelectric potential
                                    of a non-federally owned
                                    conduit.
FPA 30(a)(3)(C)(ii)..............  The facility has an                Y
                                    installed capacity that
                                    does not exceed 40
                                    megawatts.
FPA 30(a)(3)(C)(iii).............  On or before August 9,             Y
                                    2013, the facility is
                                    not licensed, or
                                    exempted from the
                                    licensing requirements
                                    of Part I of the FPA.
------------------------------------------------------------------------

    Preliminary Determination: The proposed M5E Pressure Reducing
Station Hydroelectric Project will not alter the primary purpose of the
conduit, which is to supply potable water to the City of Palmdale and
surrounding areas. Therefore, based upon the above criteria, Commission
staff preliminarily determines that the proposal satisfies the
requirements for a qualifying conduit hydropower facility, which is not
required to be licensed or exempted from licensing.
    Comments and Motions to Intervene: Deadline for filing comments
contesting whether the facility meets the qualifying criteria is 30
days from the issuance date of this notice.
    Deadline for filing motions to intervene is 30 days from the
issuance date of this notice.
    Anyone may submit comments or a motion to intervene in accordance
with the requirements of Rules of Practice and Procedure, 18 CFR
385.210 and 385.214. Any motions to intervene must be received on or
before the specified

deadline date for the particular proceeding.
    Filing and Service of Responsive Documents: All filings must (1)
bear in all capital letters the ``COMMENTS CONTESTING QUALIFICATION FOR
A CONDUIT HYDROPOWER FACILITY'' or ``MOTION TO INTERVENE,'' as
applicable; (2) state in the heading the name of the applicant and the
project number of the application to which the filing responds; (3)
state the name, address, and telephone number of the person filing; and
(4) otherwise comply with the requirements of sections 385.2001 through
385.2005 of the Commission's regulations.\1\ All comments contesting
Commission staff's preliminary determination that the facility meets
the qualifying criteria must set forth their evidentiary basis.
---------------------------------------------------------------------------

    \1\ 18 CFR 385.2001-2005 (2019).
---------------------------------------------------------------------------

    The Commission strongly encourages electronic filing. Please file
motions to intervene and comments using the Commission's eFiling system
at http://www.ferc.gov/docs-filing/efiling.asp. Commenters can submit
brief comments up to 6,000 characters, without prior registration,
using the eComment system at http://www.ferc.gov/docs-filing/ecomment.asp. You must include your name and contact information at the
end of your comments. For assistance, please contact FERC Online
Support at<EMAIL_ADDRESS>(866) 208-3676 (toll free), or
(202) 502-8659 (TTY). In lieu of electronic filing, you may send a
paper copy. Submissions sent via the U.S. Postal Service must be
addressed to: Kimberly D. Bose, Secretary, Federal Energy Regulatory
Commission, 888 First Street NE, Room 1A, Washington, DC 20426.
Submissions sent via any other carrier must be addressed to: Kimberly
D. Bose, Secretary, Federal Energy Regulatory Commission, 12225 Wilkins
Avenue, Rockville, Maryland 20852. A copy of all other filings in
reference to this application must be accompanied by proof of service
on all persons listed in the service list prepared by the Commission in
this proceeding, in accordance with 18 CFR 385.2010.
    Locations of Notice of Intent: The Commission provides all
interested persons an opportunity to view and/or print the contents of
this document via the internet through the Commission's website at
http://www.ferc.gov/docs-filing/elibrary.asp. Enter the docket number
(i.e., CD20-7) in the docket number field to access the document. You
may also register online at http://www.ferc.gov/docs-filing/esubscription.asp to be notified via email of new filings and issuances
related to this or other pending projects. Copies of the notice of
intent can be obtained directly from the applicant. At this time, the
Commission has suspended access to the Commission's Public Reference
Room due to the proclamation declaring a National Emergency concerning
the Novel Coronavirus Disease (COVID-19), issued by the President on
March 13, 2020. For assistance, call toll-free 1-866-208-3676 or email
<EMAIL_ADDRESS>For TTY, call<PHONE_NUMBER>.

    Dated: July 13, 2020.
Kimberly D. Bose,
Secretary.
[FR Doc. 2020-15484 Filed 7-16-20; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 221 (Friday, November 15, 2019)]
[Notices]
[Page 62530]
[FR Doc No: 2019-24810]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[ER-FRL-9047-9]

Environmental Impact Statements; Notice of Availability

    Responsible Agency: Office of Federal Activities, General
Information<PHONE_NUMBER> or https://www.epa.gov/nepa/.

Weekly receipt of Environmental Impact Statements
Filed 11/04/2019 10 a.m. ET Through 11/11/2019 10 a.m. ET
Pursuant to 40 CFR 1506.9.

Notice

    Section 309(a) of the Clean Air Act requires that EPA make public
its comments on EISs issued by other Federal agencies. EPA's comment
letters on EISs are available at: https://cdxnodengn.epa.gov/cdx-enepa-public/action/eis/search.

EIS No. 20190270, Final, NMFS, LA, Reduce the Incidental Bycatch and
Mortality of Sea Turtles in the Southeastern U.S. Shrimp Fisheries,
Review Period Ends: 12/16/2019, Contact: Michael Barnette<PHONE_NUMBER>
EIS No. 20190271, Final, USACE, CA, Lower Elkhorn Basin Levee Setback
Project, Review Period Ends: 12/16/2019, Contact: Tanis Toland 916-557-
6717
EIS No. 20190272, Draft Supplement, USACE, AL, Allatoona Lake Water
Supply Storage Reallocation Study and Updates to Weiss and Logan Martin
Reservoirs Project Water Control Manuals, Comment Period Ends: 12/30/
2019, Contact: Jennifer Jacobson<PHONE_NUMBER>

    Dated: November 12, 2019.
Robert Tomiak,
Director, Office of Federal Activities.
[FR Doc. 2019-24810 Filed 11-14-19; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register: May 29, 2008 (Volume 73, Number 104)]
[Notices]
[Page 30949-30950]
[DOCID:fr29my08-73]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2007-E-0461 (formerly Docket No. 2007E-0424), FDA-
2007-E-0165 (formerly Docket No. 2007E-0425), FDA-2007-E-0459 (formerly
Docket No. 2007E-0146)]

Determination of Regulatory Review Period for Purposes of Patent
Extension; LUCENTIS

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY:  The Food and Drug Administration (FDA) has determined the
regulatory review period for LUCENTIS and is publishing this notice of
that determination as required by law. FDA has made the determination
because of the submission of applications to the Director of Patents
and Trademarks, Department of Commerce, for the extension of patents
which claim that human biological product.

ADDRESSES:  Submit written or electronic comments and petitions to the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic
comments to http://www.regulations.gov.

FOR FURTHER INFORMATION CONTACT:  Beverly Friedman, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, rm. 6222, Silver Spring, MD, 20993-0002, 301-
796-3602.

SUPPLEMENTARY INFORMATION: The Drug Price Competition and Patent Term
Restoration Act of 1984 (Public Law 98-417) and the Generic Animal Drug
and Patent Term Restoration Act (Public Law 100-670) generally provide
that a patent may be extended for a period of up to 5 years so long as
the patented item (human drug product, animal drug product, medical
device, food additive, or color additive) was subject to regulatory
review by FDA before the item was marketed. Under these acts, a
product's regulatory review period forms the basis for determining the
amount of extension an applicant may receive.
    A regulatory review period consists of two periods of time: A
testing phase and an approval phase. For human biological products, the
testing phase begins when the exemption to permit the clinical
investigations of the biological product becomes effective

and runs until the approval phase begins. The approval phase starts
with the initial submission of an application to market the human
biological product and continues until FDA grants permission to market
the biological product. Although only a portion of a regulatory review
period may count toward the actual amount of extension that the
Director of Patents and Trademarks may award (for example, half the
testing phase must be subtracted as well as any time that may have
occurred before the patent was issued), FDA's determination of the
length of a regulatory review period for a human biological product
will include all of the testing phase and approval phase as specified
in 35 U.S.C. 156(g)(1)(B).
    FDA recently approved for marketing the human biologic product
LUCENTIS (ranibizumab). LUCENTIS is indicated for the treatment of
patients with neovascular (wet) age-related macular degeneration.
Subsequent to this approval, the Patent and Trademark Office received
patent term restoration applications for LUCENTIS (U.S. Patent Nos.
6,407,213; 6,884,879; and 7,060,269) from Genentech, Inc., and the
Patent and Trademark Office requested FDA's assistance in determining
this patent's eligibility for patent term restoration. In letters dated
July 24, 2007, and November 21, 2007, FDA advised the Patent and
Trademark Office that this human biological product had undergone a
regulatory review period and that the approval of LUCENTIS represented
the first permitted commercial marketing or use of the product. Shortly
thereafter, the Patent and Trademark Office requested that FDA
determine the product's regulatory review period.
    FDA has determined that the applicable regulatory review period for
LUCENTIS is 2,430 days. Of this time, 2,247 days occurred during the
testing phase of the regulatory review period, while 183 days occurred
during the approval phase. These periods of time were derived from the
following dates:
    1. The date an exemption under section 505(i) of the Federal Food,
Drug, and Cosmetic Act (21 U.S.C. 355(i)) became effective: November 6,
1999. The applicant claims October 7, 1999, as the date the
investigational new drug application (IND) became effective. However,
FDA records indicate that the IND effective date was November 6, 1999,
which was 30 days after FDA receipt of the IND.
    2. The date the application was initially submitted with respect to
the human biological product under section 351 of the Public Health
Service Act (42 U.S.C. 262): December 30, 2005. The applicant claims
December 29, 2005, as the date the biologics license application (BLA)
for LUCENTIS (BLA 125156/0) was initially submitted. However, FDA
records indicate that BLA 125156/0 was submitted on December 30, 2005.
    3. The date the application was approved: June 30, 2006. FDA has
verified the applicant's claim that BLA 125156/0 was approved on June
30, 2006.
    This determination of the regulatory review period establishes the
maximum potential length of a patent extension. However, the U.S.
Patent and Trademark Office applies several statutory limitations in
its calculations of the actual period for patent extension. In its
applications for patent extension for U.S. Patent Nos. 6,407,213;
6,884,879; and 7,060,269, this applicant seeks 378 days; 307 days or 17
days, respectively, of patent term extension.
    Anyone with knowledge that any of the dates as published are
incorrect may submit to the Division of Dockets Management (see
ADDRESSES) written or electronic comments and ask for a redetermination
by July 28, 2008. Furthermore, any interested person may petition FDA
for a determination regarding whether the applicant for extension acted
with due diligence during the regulatory review period by November 25,
2008. To meet its burden, the petition must contain sufficient facts to
merit an FDA investigation. (See H. Rept. 857, part 1, 98th Cong., 2d
sess., pp. 41-42, 1984.) Petitions should be in the format specified in
21 CFR 10.30.
    Comments and petitions should be submitted to the Division of
Dockets Management. Three copies of any mailed information are to be
submitted, except that individuals may submit one copy. Comments are to
be identified with the docket number found in brackets in the heading
of this document. Comments and petitions may be seen in the Division of
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.
    Please note that on January 15, 2008, the FDA Division of Dockets
Management Web site transitioned to the Federal Dockets Management
System (FDMS). FDMS is a Government-wide, electronic docket management
system. Electronic comments or submissions will be accepted by FDA only
through FDMS at http://www.regulations.gov.

    Dated: May 8, 2008.
Jane A. Axelrad,
Associate Director for Policy, Center for Drug Evaluation and Research.
[FR Doc. E8-12007 Filed 5-28-08; 8:45 am]

BILLING CODE 4160-01-S


[Federal Register: April 6, 2006 (Volume 71, Number 66)]
[Notices]
[Page 17463-17464]
[DOCID:fr06ap06-64]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP06-226-000]

El Paso Natural Gas Company; Notice of Request of Waiver

March 30, 2006.
    Take notice that on February 16, 2006, El Paso Natural Gas Company
(El Paso) filed proposals for the month of January 2006 to discount its
new Order No. 637 daily overrun charges, as well as to waive any
monthly cash-out charges resulting from the tiers in El Paso's cash-out
mechanism. El Paso states that the filing is being made as an
accommodation to shippers to give them more time to adjust to these new
tariff provisions.

    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed in accordance with the provisions of
Section 154.210 of the Commission's regulations (18 CFR 154.210).
Anyone filing an intervention or protest must serve a copy of that
document on the Applicant. Anyone filing an intervention or protest on
or before the intervention or protest date need not serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible online at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
[FR Doc. E6-4968 Filed 4-5-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 88, Number 42 (Friday, March 3, 2023)]
[Rules and Regulations]
[Pages 13301-13303]
[FR Doc No: 2023-04255]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2022-1253; Project Identifier MCAI-2022-00698-T;
Amendment 39-22349; AD 2023-04-02]
RIN 2120-AA64

Airworthiness Directives; Gulfstream Aerospace LP Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The FAA is adopting a new airworthiness directive (AD) for all
Gulfstream Aerospace LP Model Gulfstream G280 airplanes. This AD was
prompted by a determination that the existing wet runway performance
tables in the airplane flight manual (AFM) may not provide an
acceptable level of safety. This AD requires revising the existing AFM
to incorporate new wet runway performance tables, as specified in a
Civil Aviation Authority of Israel (CAAI) AD, which is incorporated by
reference. The FAA is issuing this AD to address the unsafe condition
on these products.

DATES: This AD is effective April 7, 2023.
    The Director of the Federal Register approved the incorporation by
reference of a certain publication listed in this AD as of April 7,
2023.

ADDRESSES:
    AD Docket: You may examine the AD docket at regulations.gov under
Docket No. FAA-2022-1253; or in person at Docket Operations between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays. The AD
docket contains this final rule, the mandatory continuing airworthiness
information (MCAI), any comments received, and other information. The
address for Docket Operations is U.S. Department of Transportation,
Docket Operations, M-30, West Building Ground Floor, Room W12-140, 1200
New Jersey Avenue SE, Washington, DC 20590.
    Material Incorporated by Reference:
     For material incorporated by reference in this AD, contact
CAAI, P.O. Box 1101, Golan Street, Airport City, 70100, Israel;
telephone 972-3-9774665; fax 972-3-9774592; email [email protected]. You
may find this material on the CAAI website at caa.gov.il.
     You may view this material at the FAA, Airworthiness
Products Section, Operational Safety Branch, 2200 South 216th St., Des
Moines, WA. For information on the availability of this material at the
FAA, call<PHONE_NUMBER>. It is also available in the AD docket at
regulations.gov under Docket No. FAA-2022-1253.

FOR FURTHER INFORMATION CONTACT: Dan Rodina, Aerospace Engineer, Large
Aircraft Section, FAA, International Validation Branch, 2200 South
216th St., Des Moines, WA 98198; telephone<PHONE_NUMBER>; email
[email protected].

SUPPLEMENTARY INFORMATION:

Background

    The FAA issued a notice of proposed rulemaking (NPRM) to amend 14
CFR part 39 by adding an AD that would apply to all Gulfstream
Aerospace LP Model Gulfstream G280 airplanes. The NPRM published in the
Federal Register on October 5, 2022 (87 FR 60344). The NPRM was
prompted by AD ISR-I-97-2022-04-9, dated May 1, 2022, issued by the
Civil Aviation Authority of Israel (CAAI), which is the aviation
authority for Israel (CAAI AD ISR-I-97-2022-04-9) (also referred to as
the MCAI). The MCAI states that the existing wet runway performance
tables in the AFM may not provide an acceptable level of safety, and
that the wet runway performance tables have been updated in the
Performance section of the G280 AFM, Revision 10.
    In the NPRM, the FAA proposed to require revising the existing AFM
to incorporate new wet runway performance tables, as specified in CAAI
AD ISR-I-97-2022-04-9. The FAA is issuing this AD to address the
existing AFM wet runway performance tables that could allow the
airplane to experience runway excursions or overruns during takeoff.
    You may examine the MCAI in the AD docket at regulations.gov under
Docket No. FAA-2022-1253.

Discussion of Final Airworthiness Directive

Comments

    The FAA received comments from one individual. The following
presents the comments received on the NPRM and the FAA's response to
each comment.

Request To Produce Digital Version of AFM

    The commenter noted that the FAA should change AFMs to a digital
format so they can be updated as new ADs are created.
    The FAA issues ADs to address unsafe conditions, including those
involving the AFM. The question of whether AFMs should be produced in
another format is beyond the scope of this AD.

Request for Clarification on Adequacy of Performance Tables

    The commenter also remarked that an effort should be made to
understand why wet runway performance tables do not have an acceptable
level of safety. The commenter argued that a deficiency such as this
should have been caught during the aircraft certification process.
    Airplane certification and validation activities provide a baseline
for safety. However, it is not possible to anticipate all potential
unsafe conditions on an airplane during the certification process. Once
the airplane is in service, the FAA issues ADs in accordance with 14
CFR 39.5 when the agency subsequently finds that an unsafe condition
exists in the airplane and the condition is likely to exist or develop
in other airplanes of the same type design. The FAA has not changed
this AD as a result of this comment.

Conclusion

    This product has been approved by the aviation authority of another
country and is approved for operation in the United States. Pursuant to
the FAA's bilateral agreement with this State of Design Authority, it
has notified the FAA of the unsafe condition described in the MCAI
referenced above. The FAA reviewed the relevant data, considered the
comments received, and determined that air safety requires adopting
this AD as proposed. Accordingly, the FAA is issuing this AD to address
the unsafe condition on this product. Except for minor editorial
changes, this AD is adopted as proposed in the NPRM. None of the
changes will increase the economic burden on any operator.

Related Service Information Under 1 CFR Part 51

    CAAI AD ISR-I-97-2022-04-9 specifies procedures for updating the
Performance section of the G280 AFM to incorporate new wet runway
tables. This material is reasonably available because the interested
parties have access to it through their normal course of business or by
the means identified in the ADDRESSES section.

Costs of Compliance

    The FAA estimates that this AD would affect 195 airplanes of U.S.
registry. The FAA estimates the following costs to comply with this AD:

                                      Estimated Costs for Required Actions
----------------------------------------------------------------------------------------------------------------
                                                                                Cost per       Cost on U.S.
                          Labor cost                              Parts cost        product         operators
----------------------------------------------------------------------------------------------------------------
1 work-hour x $85 per hour = $85.............................              $0              $85          $16,575
----------------------------------------------------------------------------------------------------------------

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. Subtitle VII: Aviation Programs,
describes in more detail the scope of the Agency's authority.
    The FAA is issuing this rulemaking under the authority described in
Subtitle VII, Part A, Subpart III, Section 44701: General requirements.
Under that section, Congress charges the FAA with promoting safe flight
of civil aircraft in air commerce by prescribing regulations for
practices, methods, and procedures the Administrator finds necessary
for safety in air commerce. This regulation is within the scope of that
authority because it addresses an unsafe condition that is likely to
exist or develop on products identified in this rulemaking action.

Regulatory Findings

    This AD will not have federalism implications under Executive Order
13132. This AD will not have a substantial direct effect on the States,
on the relationship between the national government and the States, or
on the distribution of power and responsibilities among the various
levels of government.
    For the reasons discussed above, I certify that this AD:
    (1) Is not a ``significant regulatory action'' under Executive
Order 12866,
    (2) Will not affect intrastate aviation in Alaska, and
    (3) Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA amends 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

0
1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

0
2. The FAA amends Sec.  39.13 by adding the following new airworthiness
directive:

2023-04-02 Gulfstream Aerospace LP: Amendment 39-22349; Docket No.
FAA-2022-1253; Project Identifier MCAI-2022-00698-T.

(a) Effective Date

    This airworthiness directive (AD) is effective April 7, 2023.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to all Gulfstream Aerospace LP Model Gulfstream
G280 airplanes, certificated in any category.

(d) Subject

    Air Transport Association (ATA) of America Code 34, Navigation.

(e) Unsafe Condition

    This AD was prompted by a determination that the existing wet
runway performance tables in the airplane flight manual (AFM) may
not provide an acceptable level of safety. The FAA is issuing this
AD to address the existing AFM wet runway performance tables that
could allow the airplane to experience runway excursions or overruns
during takeoff.

(f) Compliance

    Comply with this AD within the compliance times specified,
unless already done.

(g) Requirements

    Except as specified in paragraph (h) of this AD: Comply with all
required actions and

compliance times specified in, and in accordance with, Civil
Aviation Authority of Israel (CAAI) AD ISR-I-97-2022-04-9, dated May
1, 2022 (CAAI AD ISR-I-97-2022-04-9).

(h) Exception to CAAI AD ISR-I-97-2022-04-9

    Where CAAI AD ISR-I-97-2022-04-9 refers to its effective date,
this AD requires using the effective date of this AD.

(i) Additional AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager,
Large Aircraft Section, International Validation Branch, FAA, has
the authority to approve AMOCs for this AD, if requested using the
procedures found in 14 CFR 39.19. In accordance with 14 CFR 39.19,
send your request to your principal inspector or responsible Flight
Standards Office, as appropriate. If sending information directly to
the Large Aircraft Section, International Validation Branch, send it
to the attention of the person identified in paragraph (j) of this
AD. Information may be emailed to: [email protected].
Before using any approved AMOC, notify your appropriate principal
inspector, or lacking a principal inspector, the manager of the
responsible Flight Standards Office.
    (2) Contacting the Manufacturer: For any requirement in this AD
to obtain instructions from a manufacturer, the instructions must be
accomplished using a method approved by the Manager, Large Aircraft
Section, International Validation Branch, FAA; or CAAI; or CAAI's
authorized Designee. If approved by the CAAI Designee, the approval
must include the Designee's authorized signature.

(j) Additional Information

    For more information about this AD, contact Dan Rodina,
Aerospace Engineer, Large Aircraft Section, FAA, International
Validation Branch, 2200 South 216th St., Des Moines, WA 98198;
telephone<PHONE_NUMBER>; email [email protected].

(k) Material Incorporated by Reference

    (1) The Director of the Federal Register approved the
incorporation by reference of the service information listed in this
paragraph under 5 U.S.C. 552(a) and 1 CFR part 51.
    (2) You must use this service information as applicable to do
the actions required by this AD, unless this AD specifies otherwise.
    (i) Civil Aviation Authority of Israel (CAAI) AD ISR-I-97-2022-
04-9, dated May 1, 2022.
    (ii) [Reserved]
    (3) For CAAI AD ISR-I-97-2022-04-9, contact Civil Aviation
Authority of Israel (CAAI), P.O. Box 1101, Golan Street, Airport
City, 70100, Israel; telephone 972-3-9774665; fax 972-3-9774592;
email [email protected]. You may find this CAAI AD on the CAAI website
at caa.gov.il.
    (4) You may view this material at the FAA, Airworthiness
Products Section, Operational Safety Branch, 2200 South 216th St.,
Des Moines, WA. For information on the availability of this material
at the FAA, call<PHONE_NUMBER>.
    (5) You may view this material that is incorporated by reference
at the National Archives and Records Administration (NARA). For
information on the availability of this material at NARA, email
[email protected], or go to: www.archives.gov/federal-register/cfr/ibr-locations.html.

    Issued on February 14, 2023.
Christina Underwood,
Acting Director, Compliance & Airworthiness Division, Aircraft
Certification Service.
[FR Doc. 2023-04255 Filed 3-2-23; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register Volume 77, Number 43 (Monday, March 5, 2012)]
[Notices]
[Pages 13122-13123]
[FR Doc No: 2012-5254]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OAR-2008-0707; Notice-3; FRL-9643-1]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Data Reporting Requirements for State and Local
Vehicle Emission Inspection and Maintenance (I/M) Programs

AGENCY: Environmental Protection Agency.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et seq.), this document announces that EPA is planning to
submit a request to renew an existing approved Information Collection
Request (ICR) to the Office of Management and Budget (OMB). This ICR is
scheduled to expire on August 31, 2012. Before submitting the ICR to
OMB for review and approval, EPA is soliciting comments on specific
aspects of the proposed information collection as described below.

DATES: Comments must be submitted on or before May 4, 2012.

ADDRESSES: Submit your comments, identified by Docket ID No. EPA-HQ-
OAR-2008-0707: Notice-3, by one of the following methods:
     www.regulations.gov: Follow the on-line instructions for
submitting comments.
     Email<EMAIL_ADDRESS>     Fax:<PHONE_NUMBER>.
     Mail: U.S. Environmental Protection Agency, EPA West (Air
Docket), Mailcode: 6102T, 1200 Pennsylvania Ave NW., Room: B108,
Washington, DC 20460.
     Hand Delivery: EPA Docket Center (Air Docket), U.S.
Environmental Protection Agency, 1301 Constitution Avenue NW., Room:
B108; Mail Code: 6102T, Washington, DC 20004. Such deliveries are only
accepted during the Docket's normal hours of operation, and special
arrangements should be made for deliveries of boxed information.
    Instructions: Direct your comments to Docket ID No. EPA-HQ-OAR-
2008-0707: Notice-3. EPA's policy is that all comments received will be
included in the public docket without change and may be made available
online at www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through www.regulations.gov
or email. The www.regulations.gov Web site is an ``anonymous access''
system, which means EPA will not know your identity or contact
information unless you provide it in the body of your comment. If you
send an email comment directly to EPA without going through
www.regulations.gov your email address will be automatically captured
and included as part of the comment that is placed in the public docket
and made available on the Internet. If you submit an electronic
comment, EPA recommends that you include your name and other contact
information in the body of your comment and with any disk or CD-ROM you
submit. If EPA cannot read your comment due to technical difficulties
and cannot contact you for clarification, EPA may not be able to
consider your comment. Electronic files should avoid the use of special
characters, any form of encryption, and be free of any defects or
viruses. For additional information about EPA's public docket visit the
EPA Docket Center homepage at http://www.epa.gov/epahome/dockets.htm.

FOR FURTHER INFORMATION CONTACT: Dave Sosnowski, Environmental
Protection Agency, Office of Transportation and Air Quality,
Transportation and Climate Division, 2000 Traverwood, Ann Arbor,
Michigan 48105; telephone number:<PHONE_NUMBER>; fax number: (734)
214-4052; email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

How can I access the docket and/or submit comments?

    EPA has established a public docket for this ICR under Docket ID
No. EPA-HQ-OAR-2008-0707: Notice-3, which is available for online
viewing at www.regulations.gov, or in person viewing at the Air Docket
in the EPA Docket Center (EPA/DC), EPA West, Room 3334, 1301
Constitution Ave NW., Washington, DC. The EPA/DC Public Reading Room is
open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding
legal holidays. The telephone number for the Reading Room is (202) 566-
1744, and the telephone number for the Air Docket is<PHONE_NUMBER>.
    Use www.regulations.gov to obtain a copy of the draft collection of
information, submit or view public comments, access the index listing
of the contents of the docket, and to access those documents in the
public docket that are available electronically. Once in the system,
select ``search,'' then key in the docket ID number identified in this
document.

What information is EPA particularly interested in?

    Pursuant to section 3506(c)(2)(A) of the PRA, EPA specifically
solicits comments and information to enable it to:
    (i) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the Agency,
including whether the information will have practical utility;
    (ii) Evaluate the accuracy of the Agency's estimate of the burden
of the proposed collection of information, including the validity of
the methodology and assumptions used;
    (iii) Enhance the quality, utility, and clarity of the information
to be collected; and
    (iv) Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses. In particular, EPA is requesting comments from
very small businesses (those that employ less than 25) on examples of
specific additional efforts that EPA could make to reduce the paperwork
burden for very small businesses affected by this collection.

What should I consider when I prepare my comments for EPA?

    You may find the following suggestions helpful for preparing your
comments:

    1. Explain your views as clearly as possible and provide specific
examples.
    2. Describe any assumptions that you used.
    3. Provide copies of any technical information and/or data you used
that support your views.
    4. If you estimate potential burden or costs, explain how you
arrived at the estimate that you provide.
    5. Offer alternative ways to improve the collection activity.
    6. Make sure to submit your comments by the deadline identified
under DATES.
    7. To ensure proper receipt by EPA, be sure to identify the docket
ID number assigned to this action in the subject line on the first page
of your response. You may also provide the name, date, and Federal
Register citation.

What information collection activity or ICR does this apply to?

    Docket ID No. EPA-HQ-OAR-2008-0707: Notice-3.
    Affected entities: Entities potentially affected by this action are
the state government agencies or departments responsible for oversight
and operation of the I/M programs (SIC91). Thirty-three states
plus the District of Columbia will be affected by I/M program
requirements.
    Title: Data Reporting Requirements for State and Local Vehicle
Emission Inspection and Maintenance (I/M) Programs.
    ICR numbers: EPA ICR No. 1613.03, OMB Control No. 2060-0252.
    ICR status: This ICR is currently scheduled to expire on August 31,
2012. An Agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information, unless it displays
a currently valid OMB control number. The OMB control numbers for EPA's
regulations in title 40 of the CFR, after appearing in the Federal
Register when approved, are listed in 40 CFR part 9, are displayed
either by publication in the Federal Register or by other appropriate
means, such as on the related collection instrument or form, if
applicable. The display of OMB control numbers in certain EPA
regulations is consolidated in 40 CFR part 9.
    Abstract: To provide general oversight and support to state and
local I/M programs, the Transportation and Regional Programs Division
(TRPD), Office of Transportation and Air Quality, Office of Air and
Radiation, U. S. Environmental Protection Agency, requires that state
or local program management for both basic and enhanced I/M programs
collect two varieties of reports to EPA. The first reporting
requirement is the submittal of an annual report providing general
program operating data and summary statistics, addressing the program's
current design and coverage, a summary of testing data, enforcement
program efforts, quality assurance and quality control efforts, and
other miscellaneous information allowing for an assessment of the
program's relative effectiveness; the second is a biennial report on
any changes to the program over the two-year period and the impact of
such changes, including any weaknesses discovered and corrections made
or planned.
    General program effectiveness is determined by the degree to which
a program misses, meets, or exceeds the emission reductions committed
to in the state's approved SIP, which, in turn, must meet or exceed the
minimum emission reductions expected from the relevant performance
standard, as promulgated under EPA's revisions to 40 CFR, Part 51, in
response to requirements established in section 182 of the Clean Air
Act Amendments of 1990 (Act). This information will be used by EPA to
determine a program's progress toward meeting requirements under 40
CFR, Part 51, as well as to assess national trends in the area of basic
and enhanced I/M programs and to provide background information in
support of periodic site visits and evaluations.
    Burden Statement: The annual public reporting and recordkeeping
burden for this collection of information is estimated to average 85
hours per response. Burden means the total time, effort, or financial
resources expended by persons to generate, maintain, retain, or
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; develop, acquire,
install, and utilize technology and systems for the purposes of
collecting, validating, and verifying information, processing and
maintaining information, and disclosing and providing information;
adjust the existing ways to comply with any previously applicable
instructions and requirements which have subsequently changed; train
personnel to be able to respond to a collection of information; search
data sources; complete and review the collection of information; and
transmit or otherwise disclose the information.
    The ICR provides a detailed explanation of the Agency's estimate,
which is only briefly summarized here:
    Estimated total number of potential respondents: 28.
    Frequency of response: Annual and Biennial.
    Estimated total average number of responses for each respondent: 1.
    Estimated total annual burden hours: 2,380 hours.
    Estimated total annual costs: $144,564. This includes an estimated
burden cost of $144,564 and an estimated cost of $0 for capital
investment or maintenance and operational costs.

Are there changes in the estimates from the last approval?

    There is a change in the total estimated respondent burden compared
with that identified in the ICR currently approved by OMB due to
increased Office of Personnel Management estimates for labor costs for
clerical, technical, and management personnel. The total cost and
burden associated with this ICR has gone down, however, due to a
reduction in the number of respondents covered by the collection.

What is the next step in the process for this ICR?

    EPA will consider the comments received and amend the ICR as
appropriate. The final ICR package will then be submitted to OMB for
review and approval pursuant to 5 CFR 1320.12. At that time, EPA will
issue another Federal Register notice pursuant to 5 CFR
1320.5(a)(1)(iv) to announce the submission of the ICR to OMB and the
opportunity to submit additional comments to OMB. If you have any
questions about this ICR or the approval process, please contact the
technical person listed under FOR FURTHER INFORMATION CONTACT.

    Dated: February 28, 2012.
Karl Simon,
Director, Transportation and Climate Division, Office of Office of
Transportation and Air Quality.
[FR Doc. 2012-5254 Filed 3-2-12; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 84, Number 214 (Tuesday, November 5, 2019)]
[Notices]
[Pages 59672-59673]
[FR Doc No: 2019-24101]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2019-0230]

Qualification of Drivers; Exemption Applications; Implantable
Cardioverter Defibrillators

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of applications for exemption; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from six individuals
for an exemption from the prohibition in the Federal Motor Carrier
Safety Regulations (FMCSRs) against operation of a commercial motor
vehicle (CMV) by persons with a current clinical diagnosis of
myocardial infarction, angina pectoris, coronary insufficiency,
thrombosis, or any other cardiovascular disease of a variety known to
be accompanied by syncope (transient loss of consciousness), dyspnea
(shortness of breath), collapse, or congestive heart failure. If
granted, the exemptions would enable these individuals with implantable
cardioverter defibrillators (ICDs) to operate CMVs in interstate
commerce.

DATES: Comments must be received on or before December 5, 2019.

ADDRESSES: You may submit comments identified by the Federal Docket
Management System (FDMS) Docket ID FMCSA-2019-0230 using any of the
following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov/docket?D=FMCSA-2019-0230. Follow the online
instructions for submitting comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE, West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue SE, Washington, DC, between 9 a.m. and 5 p.m.,
ET, Monday through Friday, except Federal Holidays.
     Fax:<PHONE_NUMBER>.
    To avoid duplication, please use only one of these four methods.
See the ``Public Participation'' portion of the SUPPLEMENTARY
INFORMATION section for instructions on submitting comments.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA,
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224,
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m.,
ET, Monday through Friday, except Federal holidays. If you have
questions regarding viewing or submitting material to the docket,
contact Docket Operations,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Submitting Comments

    If you submit a comment, please include the docket number for this
notice (Docket No. FMCSA-2019-0230), indicate the specific section of
this document to which each comment applies, and provide a reason for
each suggestion or recommendation. You may submit your comments and
material online or by fax, mail, or hand delivery, but please use only
one of these means. FMCSA recommends that you include your name and a
mailing address, an email address, or a phone number in the body of
your document so that FMCSA can contact you if there are questions
regarding your submission.
    To submit your comment online, go http://www.regulations.gov/docket?D=FMCSA-2019-0230. Click on the ``Comment Now!'' button and type
your comment into the text box on the following screen. Choose whether
you are submitting your comment as an individual or on behalf of a
third party and then submit.
    If you submit your comments by mail or hand delivery, submit them
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for
copying and electronic filing. If you submit comments by mail and would
like to know that they reached the facility, please enclose a stamped,
self-addressed postcard or envelope.
    FMCSA will consider all comments and material received during the
comment period.

B. Viewing Documents and Comments

    To view comments, as well as any documents mentioned in this notice
as being available in the docket, go to http://www.regulations.gov/docket?D=FMCSA-2019-0230 and choose the document to review. If you do
not have access to the internet, you may view the docket online by
visiting the Docket Management Facility in Room W12-140 on the ground
floor of the DOT West Building, 1200 New Jersey Avenue SE, Washington,
DC 20590, between 9 a.m. and 5 p.m., ET, Monday through Friday, except
Federal holidays.

C. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the
public to better inform its rulemaking process. DOT posts these
comments, without edit, including any personal information the
commenter provides, to www.regulations.gov, as described in the system
of records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.

II. Background

    Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption
from the FMCSRs for no longer than a 5-year period if it finds such
exemption would likely achieve a level of safety that is equivalent to,
or greater than, the level that would be achieved absent such
exemption. The statute also allows the Agency to renew exemptions at
the end of the 5-year period. FMCSA grants medical exemptions from the
FMCSRs for a 2-year period to align with the maximum duration of a
driver's medical certification.
    The six individuals listed in this notice have requested an
exemption from 49 CFR 391.41(b)(4). Accordingly, the Agency will
evaluate the qualifications of each applicant to determine whether
granting the exemption will achieve the required level of safety
mandated by statute.
    The physical qualification standard found in Sec.  391.41(b)(4)
states that a person is physically qualified to drive a CMV if that
person has no current clinical diagnosis of myocardial infarction,
angina pectoris, coronary insufficiency, thrombosis, or any other
cardiovascular disease of a variety known to be accompanied by syncope,
dyspnea, collapse, or congestive cardiac failure.
    In addition to the regulations, FMCSA has published advisory
criteria \1\ to assist medical examiners in determining whether drivers
with certain medical

conditions are qualified to operate a CMV in interstate commerce. The
advisory criteria states that ICDs are disqualifying due to risk of
syncope.
---------------------------------------------------------------------------

    \1\ These criteria may be found in 49 CFR part 391, APPENDIX A
TO PART 391--MEDICAL ADVISORY CRITERIA, section D. Cardiovascular:
Sec.  391.41(b)(4), paragraph 4, which is available on the internet
at https://www.gpo.gov/fdsys/pkg/CFR-2015-title49-vol5/pdf/CFR-2015-title49-vol5-part391-appA.pdf.
---------------------------------------------------------------------------

III. Qualifications of Applicants

John Gittenmeier

    Mr. Gittenmeier is a commercial motor vehicle driver in Missouri.
An August 2019, letter from Mr. Gittenmeier's cardiologist reports that
his ICD was implanted in May of 2018, and that he denies any symptoms
of palpitations, rapid heartbeat, shortness of breath, chest pains,
syncope, or edema. His cardiologist reports that his most recent
ejection fraction in 2018, was 40 percent.

Charles Huff

    Mr. Huff is a commercial motor vehicle driver in Ohio. A July 2019,
letter from his cardiologist reports that his ICD was implanted in
2012. Mr. Huff's cardiologist reports that he has episodes of non-
sustained ventricular arrhythmia but has no countershock, that he had
ATPs, (antitachycardia pacing) and that his ejection fraction is around
40 percent. Mr. Huff has an ``Intrastate Only'' Ohio Public Utilities
Medical Examiner's Provisional Certificate that expires December 8,
2019. Mr. Huff seeks to operate a CMV in interstate commerce into the
States of Indiana, Pennsylvania, and Michigan, for a distance of no
more than 50 miles for a two-year period for each of the three States.

Brian Hullopeter

    Mr. Hullopeter is a commercial motor vehicle driver in Minnesota. A
July 2019, letter from his cardiologists reports that Mr. Hullopeter's
ICD device was implanted in May of 2017, and has not deployed. His last
echocardiogram showed normal left ventricular size and function.

Gaetano Letizia

    Mr. Letizia is commercial driver in New Jersey. Letters dated July
2019, from his cardiologists report that Mr. Gaetano's CRT-ICD was
implanted in September 2017, and over the past year he has not received
any shocks or therapies from the defibrillator. His most recent June
2019, ejection fraction was measured between 35 and 40 percent. His
cardiologist's letter reports that he is stable from a cardiac
standpoint.

Corey Tugwell

    Mr. Tugwell is a Class A CDL holder in Oklahoma. A September 2019,
letter from Mr. Tugwell's cardiologist reports that his initial ICD
implantation was in July of 2011. His cardiologist reports that Mr.
Tugwell has not had syncope for many years, and he has never
demonstrated any life-threatening arrhythmias or received appropriate
ICD shocks since initial implantation, that he has an ejection fraction
of 50-55 percent, and his cardiomyopathy has resolved and his current
risk of life-threatening arrhythmias or ICD shocks appears to be very
low.

Thomas Daniel Worsley

    Mr. Worsley is a commercial motor vehicle driver in Virginia. A
July 2019, letter from Mr. Worsley's cardiologist reports that his
biventricular pacemaker/ICD was implanted in October 2018, his ejection
fraction is 52 percent, he is asymptomatic and physically very active.
Mr. Worsley's cardiologist reports that he is at extremely low risk for
any sudden cardiac death as he now has a normal ejection fraction and
an implantable defibrillator which he states that by recent studies has
been shown to work 99 percent of the time.

Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315(b), FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated under the DATES
section of the notice.

    Issued on: October 30, 2019.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2019-24101 Filed 11-4-19; 8:45 am]
BILLING CODE 4910-EX-P


[Federal Register Volume 79, Number 249 (Tuesday, December 30, 2014)]
[Notices]
[Pages 78431-78432]
[FR Doc No: 2014-30519]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[FRL-9921-07-Region 6]

Draft National Pollutant Discharge Elimination System (NPDES)
General Permit for Discharges From Horse, Cattle and Dairy Concentrated
Animal Feeding Operations (CAFOs) in New Mexico (Except Indian Country)

AGENCY: Environmental Protection Agency.

ACTION: Notice of proposed permit reissuance.

-----------------------------------------------------------------------

SUMMARY: Environmental Protection Agency (EPA) Region 6 Water Quality
Protection Division is today proposing for public comment the
reissuance of a National Pollutant Discharge Elimination System general
permit (NMG010000) for discharges from eligible owners/operators of
existing concentrated animal feeding operations (CAFOs), in New Mexico,
except those discharges on Indian Country. CAFOs discharging on Indian
Country would be required to apply for an individual permit.
    This permit was originally issued with an effective date of
September 3, 2009, and an expiration date of September 2, 2014.
Conditions from the 2009 permit are continued with the following
changes proposed as part of this reissuance: (1) Removing eligibility
for coverage for ``New sources'' under the proposed permit, (2) adding
on-site rainfall measurement and record keeping, and (3) adding
requirement for paperless submittal of application documents (NOIs and
NMPs).

DATES: Comments must be submitted in writing to EPA on or before March
2, 2015.

ADDRESSES: Comments should be submitted to Ms. Evelyn Rosborough via
email<EMAIL_ADDRESS>or may be mailed to Ms. Evelyn
Rosborough, Environmental Protection Agency, Water Quality Protection
Division (6WQ-NP), 1445 Ross Ave., Suite 1200, Dallas, TX 75202.

DATES: Public Meeting: An informal public meeting is scheduled. The
meeting will include a presentation on the proposed permit followed by
the opportunity for questions and answers. Written, but not oral,
comments for the administrative record will be accepted at the public
meeting.
    Date: February 10, 2015.
    Time: 2 p.m. to 4 p.m.
    Place: Eastern New Mexico State University--Roswell, Occupational
Technology Center, Seminar Room 124, 20 West Mathis, Roswell, New
Mexico 88202-6000.
    Public Hearings: No public hearing is scheduled at this time;
however, interested persons may request a public hearing pursuant to 40
CFR 124.12 concerning the proposed permit. Requests for a public
hearing must be sent or delivered in writing to the same address as
provided above for public comments prior to the close of the comment
period. Requests for a public hearing must state the nature of the
issues proposed to be raised in the hearing. Pursuant to 40 CFR 124.12,
EPA shall hold a public hearing if it finds, on the basis of requests,
a significant degree of public interest in a public hearing on the
proposed permit.

If EPA decides to hold a public hearing, a public notice of the date,
time and place of the hearing will be made at least 30 days prior to
the hearing. Any person may provide written or oral statements and data
pertaining to the proposed permit at the public hearing.

SUPPLEMENTARY INFORMATION: A copy of the proposed permit, fact sheet,
and this Federal Register Notice may be found on the EPA Region 6 Web
site: http://www.epa.gov/region6/water/npdes/cafo/index.htm, or
obtained by contacting Ms. Rosborough via email at
<EMAIL_ADDRESS>or<PHONE_NUMBER>. The Agency's current
administrative record on the proposal is available for examination at
the Region's Dallas offices during normal working hours by providing
Ms. Rosborough 24 hours advance notice. When the final general permit
is issued, notice will be published in the Federal Register. The final
general permit will be effective on the date specified in the Federal
Register and expires five years from that date.

Other Legal Requirements

    A. State Certification. Under section 401(a)(1) of the CWA, EPA may
not issue an NPDES permit until the State in which the discharge will
occur grants or waives certification to ensure compliance with
appropriate requirements of the CWA and State law. EPA will seek
certification from the New Mexico Environment Department prior to
issuing a final permit.
    B. Endangered Species. Endangered Species Act Section 7(a)(2)
consultation between EPA and the U.S. Fish and Wildlife Service
concluded in May 29, 2009, with USFWS concurring with EPA's biological
evaluation that reissuance of the 2009 New Mexico CAFO general permit
``might affect but would be unlikely to adversely affect'' several
aquatic and aquatic dependent species federally listed in the state.
This draft permit continues those conditions of eligibility for
applicants in Bernalillo, Chavez, Eddy, Sandoval, San Juan and Valencia
Counties that were developed in consultation and made part of the 2009
general permit. EPA has reviewed listings since 2009 of new species and
critical habitat and has determined that reissuance of the permit with
the prior agreed conditions is not likely to adversely affect any
listed threatened or endangered species or designated critical habitat.
EPA will meet its responsibility to fulfill the section 7 of the ESA
requirements prior to reissuance of this general permit.
    C. Historic Preservation. EPA determined, under Section 106 of the
National Historic Preservation Act of 1966 (NHPA), that issuance of the
2009 general permit was a federal undertaking without adverse effects.
EPA finds no changes to this determination and will ensure that its
NHPA Section 16 obligation is fulfilled regarding reissuance of the
general permit.
    E. Regulatory Flexibility Act. The Regulatory Flexibility Act, 5
U.S.C. 601 et seq., requires that EPA prepare a regulatory flexibility
analysis for regulations that have a significant impact on a
substantial number of small entities. The permit reissuance proposed
today is not a ``rule'' subject to the Regulatory Flexibility Act. EPA
prepared a regulatory flexibility analysis on the promulgation of the
2003 NPDES Permit Regulation and Effluent Limitation Guidelines and
Standards for concentrated animal feeding operations (CAFOs) on which
many of the permit's effluent limitations are based. In 2013, EPA
completed review of the Guidelines and Standards pursuant to section
610 of the Regulatory Flexibility Act (RFA) and concluded that (1)
there is a continued need for the CAFO regulations, and (2) revisions
to minimize the regulations' impacts on small entities are not
warranted at this time.

    Authority: Clean Water Act, 33 U.S.C. 1251 et seq.

    Dated: December 18, 2014.
William K. Honker,
Director, Water Quality Protection Division, EPA Region 6.
[FR Doc. 2014-30519 Filed 12-29-14; 8:45 am]
BILLING CODE 6560-50-P